Common large partial VWF gene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease population

Summary.  Background: Type 3 von Willebrand disease (VWD) is an autosomal recessive bleeding disorder, characterized by virtually undetectable plasma von Willebrand factor (VWF) and consequently reduced plasma factor VIII levels. Genetic mutations responsible for type 3 VWD are very heterogeneous, scattered throughout the VWF gene and show high variability among different populations. Methods: Twenty‐five severe VWD patients were studied by direct sequencing of the 51 coding exons of the VWF gene. The total number of VWD type 3 families in Hungary is 24, of which 23 were investigated. Results: Fifteen novel mutations were identified in 31 alleles, five being nonsense mutations (p.Q1238X, p.Q1898X, p.Q1931X, p.S2505X and p.S2568X), four small deletions and insertions resulting in frame shifts (c.1992insC, c.3622delT, c.5315insGA and c.7333delG), one a large partial deletion (delExon1‐3) of the 5′‐region, four candidate missense mutations (p.C35R, p.R81G, p.C295S, p.C623T) and one a candidate splice site mutation (c.1730–10C>A). Six previously described mutations were detected in 17 alleles, including the repeatedly found c.2435delC, p.R1659X and p.R1853X. Only one patient developed alloantibodies to VWF, carrying a homozygous c.3622delT. Conclusion: We report the genetic background of the entire Hungarian type 3 VWD population. A large novel deletion, most probably due to a founder effect, seems to be unique to Hungarian type 3 VWD patients with high allele frequency. In contrast to previous reports, none of the five patients homozygous for the large partial deletion developed inhibitors to VWF. This discrepancy raises the possibility of selection bias in some of the reports.

[1]  E. Berber The Molecular Genetics of von Willebrand Disease , 2012, Turkish journal of haematology : official journal of Turkish Society of Haematology.

[2]  D. Hampshire,et al.  von Willebrand factor variant p.Arg924Gln marks an allele associated with reduced von Willebrand factor and factor VIII levels , 2010, Journal of thrombosis and haemostasis : JTH.

[3]  P. James,et al.  An assessment of the pathogenic significance of the R924Q von Willebrand factor substitution , 2009, Journal of thrombosis and haemostasis : JTH.

[4]  P. Collins,et al.  A novel deletion mutation is recurrent in von Willebrand disease types 1 and 3. , 2009, Blood.

[5]  Z. Berneman,et al.  Laboratory and Molecular Characteristics of Recessive von Willebrand Disease Type 2C (2A Subtype IIC) of Variable Severity due to Homozygous or Double Heterozygous Mutations in the D1 and D2 Domains , 2009, Acta Haematologica.

[6]  R. Marschalek,et al.  An Alu‐mediated novel large deletion is the most frequent cause of type 3 von Willebrand disease in Hungary , 2008, Journal of thrombosis and haemostasis : JTH.

[7]  R. Marschalek,et al.  A common 253‐kb deletion involving VWF and TMEM16B in German and Italian patients with severe von Willebrand disease type 3 , 2007, Journal of thrombosis and haemostasis : JTH.

[8]  R. Peñaloza,et al.  [Molecular biology of von Willebrand disease]. , 2007, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

[9]  L. O'Brien,et al.  The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study. , 2007, Blood.

[10]  P. Collins,et al.  An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease , 2006, Thrombosis and Haemostasis.

[11]  M. Lazzari,et al.  R924Q substitution encoded within exon 21 of the von Willebrand Factor gene related to mild bleeding phenotype , 2006, Thrombosis and Haemostasis.

[12]  D. Cooper,et al.  A novel Alu-mediated 61-kb deletion of the von Willebrand factor (VWF) gene whose breakpoints co-locate with putative matrix attachment regions. , 2006, Blood cells, molecules & diseases.

[13]  A. Tosetto,et al.  A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1 VWD) , 2006, Journal of thrombosis and haemostasis : JTH.

[14]  Rajiv K. Saxena,et al.  Gene conversions are a common cause of von Willebrand disease , 2005, British journal of haematology.

[15]  A. Federici Clinical diagnosis of von Willebrand disease , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

[16]  A. Goodeve,et al.  Analysis of factor VIII gene intron 1 inversion in Argentinian families with severe haemophilia A and a review of the literature , 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[17]  R. Linde,et al.  Genetic heterogeneity of severe von Willebrand disease type III in the German population , 1994, Human Genetics.

[18]  A. Srivastava,et al.  Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients. , 2003, Blood cells, molecules & diseases.

[19]  R. Favier,et al.  Two novel mutations, Q1053H and C1060R, located in the D3 domain of von Willebrand factor, are responsible for decreased FVIII‐binding capacity , 2003, British journal of haematology.

[20]  É. Fressinaud,et al.  Molecular Genetics of Type 2 von Willebrand Disease , 2002, International journal of hematology.

[21]  J. Eikenboom,et al.  Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology. , 2001, Best practice & research. Clinical haematology.

[22]  P. Mannucci,et al.  Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease. , 2000, British journal of haematology.

[23]  P. Mannucci,et al.  Molecular Characterization of a Multiethnic Group of 21 Patients with Type 3 von Willebrand Disease , 2000, Thrombosis and Haemostasis.

[24]  R. Bertina,et al.  Characterization of the Genetic Defects in Recessive Type 1 and Type 3 von Willebrand Disease Patients of Italian Origin , 1998, Thrombosis and Haemostasis.

[25]  D. Ginsburg,et al.  Von Willebrand disease. , 2008, Pediatric clinics of North America.

[26]  C. Mazurier,et al.  Characterization of von Willebrand factor gene defects in two unrelated patients with type IIC von Willebrand disease , 1994 .

[27]  P. Mannucci,et al.  Characterization of Partial Gene Deletions in Type III von Willebrand Disease with Alloantibody Inhibitors , 1994, Thrombosis and Haemostasis.

[28]  M. Blombäck,et al.  Characterization of the von Willebrand factor gene (VWF) in von Willebrand disease type III patients from 24 families of Swedish and Finnish origin. , 1994, Genomics.

[29]  P. Reitsma,et al.  Mutations in Severe, Type III von Willebrand’s Disease in the Dutch Population: Candidate Missense and Nonsense Mutations Associated with Reduced Levels of von Willebrand Factor Messenger RNA , 1992, Thrombosis and Haemostasis.

[30]  C. Mazurier,et al.  Expression of von Willebrand factor "Normandy": an autosomal mutation that mimics hemophilia A. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Cody,et al.  Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D. Mancuso,et al.  Severe type III von Willebrand's disease caused by deletion of exon 42 of the von Willebrand factor gene: family studies that identify carriers of the condition and a compound heterozygous individual. , 1990, Blood.

[33]  J. Koziol,et al.  Homozygous and heterozygous deletions of the von Willebrand factor gene in patients and carriers of severe von Willebrand disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Federici,et al.  Gene deletions correlate with the development of alloantibodies in von Willebrand disease. , 1987, The Journal of clinical investigation.

[35]  P. Mannucci,et al.  Atherosclerosis and von Willebrand factor , 1984, British journal of haematology.

[36]  P. Mannucci,et al.  Incidence of severe von Willebrand's disease. , 1982, The New England journal of medicine.